Aspirins

Taking Aspirin News

Double-Dose Plavix Benefits Certain Patients, Study FindsWednesday, September 1, 2010 @ 4:04PMWEDNESDAY, Sept. 1 (HealthDay News) -- More isn't necessarily better when prescribing the two drugs commonly used to treat patients who are in danger of having a heart attack, Plavix (clopidogrel) and aspirin, a new study suggests.

Morning business news - September 1Wednesday, September 1, 2010 @ 2:10AMAnglo's results are an obvious centre of attention here, but they also received their share of attention abroad.

Foreclosures climb higher across regionWednesday, September 1, 2010 @ 1:05AMForeclosure numbers continued their steady climb upward last month, according to numbers released yesterday by real estate data firm The Warren Group.

CYP2C19 and Plavix Response Suddenly Becomes a Gordion KnotTuesday, August 31, 2010 @ 7:24PMWith all the talk over the past several months supporting the link between CYP2C19 and Plavix efficacy you'd think the data behind it — not to mention FDA's recent Black Box warning — are incontrovertible.

Plavix Genetic-Testing Whiplash Will Lead Lab Managers to Reach for the ValiumTuesday, August 31, 2010 @ 2:09PMWith all the talk in the past several months about the link between CYP2C19 and Plavix metabolism you'd think the data behind it — not to mention FDA's recent Black Box warning — are incontrovertible.

Drug cuts stroke risk by half vs aspirin: studyTuesday, August 31, 2010 @ 11:52AMSTOCKHOLM (Reuters) - An experimental drug from Bristol-Myers Squibb and Pfizer reduces the risk of stroke by more than half compared with aspirin, with no significant rise in major bleeding, researchers said on Tuesday.

Drug cuts stroke risk by half vs aspirin: studyTuesday, August 31, 2010 @ 11:41AMAn experimental drug from Bristol-Myers Squibb and Pfizer reduces the risk of stroke by more than half compared with aspirin, with no significant rise in major bleeding, researchers said on Tuesday. Bristol-Myers Squibb - Stroke - Pfizer - Aspirin - Health

Companies Race to Develop Drugs to Reduce Blood-Clotting ProblemsTuesday, August 31, 2010 @ 6:32AMThe drugs are aimed at people who have a higher than normal risk for clotting or stroke, like patients undergoing hip replacement surgery or those with an irregular heartbeat.

Data monitoring committee recommends early termination following impressive results of AVERROES studyTuesday, August 31, 2010 @ 5:19AMThe data monitoring committee of the AVERROES study, seeing overwhelming evidence of the success of apixaban in the prevention of stroke in patients with atrial fibrillation who are unsuitable for the conventional treatment of warfarin, has recommended early termination of this study. The decision came after repeated review and careful consideration of all efficacy and safety data.